• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Methyl 2-ethoxy-6-methylbenzoate (CAS No. 104216-21-9): A Comprehensive Overview

Methyl 2-ethoxy-6-methylbenzoate, identified by its CAS number 104216-21-9, is a compound of significant interest in the field of organic chemistry and pharmaceutical research. This ester derivative of benzoic acid exhibits a unique structural framework that has garnered attention for its potential applications in various chemical and biological contexts. The presence of both ethoxy and methyl substituents on the benzene ring imparts distinct electronic and steric properties, making it a versatile candidate for further investigation.

The compound's molecular structure, characterized by a benzene ring substituted with an ethoxy group at the 2-position and a methyl group at the 6-position, contributes to its reactivity and interaction with biological systems. Such structural features are often exploited in the design of pharmaceutical agents, where specific functional groups can modulate binding affinity and metabolic stability. The benzoate moiety, in particular, is well-documented for its role in drug development, serving as a common pharmacophore in numerous therapeutic agents.

In recent years, the exploration of benzoate derivatives has expanded significantly, driven by their potential pharmacological activities. Methyl 2-ethoxy-6-methylbenzoate has been studied for its possible role as an intermediate in synthesizing more complex molecules. Its ability to undergo various chemical transformations, such as esterification and hydrolysis, makes it a valuable building block in organic synthesis. Additionally, the compound's stability under different conditions enhances its utility in industrial applications where consistent performance is crucial.

One of the most compelling aspects of Methyl 2-ethoxy-6-methylbenzoate is its potential application in the field of medicinal chemistry. Researchers have been particularly interested in its derivatives due to their demonstrated biological activity. For instance, modifications to the ethoxy and methyl groups have led to compounds with anti-inflammatory, antimicrobial, and even anticancer properties. These findings underscore the importance of structural diversity in drug discovery and highlight the significance of compounds like Methyl 2-ethoxy-6-methylbenzoate as starting points for novel therapeutic agents.

The synthesis of Methyl 2-ethoxy-6-methylbenzoate typically involves the reaction of 2-hydroxy-6-methylbenzoic acid with methanol in the presence of an acid catalyst. This straightforward synthetic route underscores the compound's accessibility, facilitating its use in both academic research and industrial-scale production. The reaction conditions can be optimized to achieve high yields and purity, ensuring that researchers have a reliable source for their experimental needs.

From a chemical perspective, Methyl 2-ethoxy-6-methylbenzoate exhibits interesting spectroscopic properties that make it useful for analytical studies. Its nuclear magnetic resonance (NMR) spectrum provides clear evidence of the functional groups present, while infrared (IR) spectroscopy confirms the ester linkage. These characteristics are invaluable for confirming the identity and purity of the compound during synthesis and characterization.

The compound's solubility profile also deserves mention. Methyl 2-ethoxy-6-methylbenzoate demonstrates moderate solubility in organic solvents such as ethanol and dichloromethane but is less soluble in water. This property influences its handling and formulation requirements, particularly when used in pharmaceutical applications where solubility can impact bioavailability.

In conclusion, Methyl 2-ethoxy-6-methylbenzoate (CAS No. 104216-21-9) is a multifaceted compound with significant potential in chemical synthesis and pharmaceutical research. Its unique structural features, coupled with its synthetic accessibility and spectroscopic characteristics, make it a valuable asset for researchers exploring new drug candidates and chemical transformations. As our understanding of molecular interactions continues to evolve, compounds like Methyl 2-ethoxy-6-methylbenzoate will undoubtedly play a crucial role in advancing both academic research and industrial applications.

• 168899-58-9(3-Acetoxy-2-methylbenzoic acid)
• 33528-09-5(Methyl 2-hydroxy-6-methylbenzoate)
• 2905-82-0(Methyl 2-hydroxy-5-methoxybenzoate)
• 479-20-9(ATRANORIN)
• 2150-40-5(Methyl 2,5-Dimethoxybenzoate)
• 28281-58-5(7-methoxy-1(3H)-Isobenzofuranone)
• 6520-83-8(Ethyl 2-methoxy-6-methylbenzoate)
• 3686-55-3(Methyl 2-ethoxybenzoate)
• 570-10-5(EVERNIC ACID)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)